Skip to main content

Table 2 Results of CCL18 and A1AT in experimental hematuria model

From: Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection

Dilution (volume of whole blood) Red blood cells ( /hpf * ) Concentration (mean ± SD) Urinary protein (dipstick test)
Hemoglobin (ng/ml) CCL18 (pg/ml) A1AT (ng/ml)
0 0 ± 0 3.63 ± 0.59 5.96 ± 7.73 1170.70 ± 71.94 negative
1/10,000 (1 μl) 0.6 ± 1.0 174.28 ± 15.69 7.06 ± 7.78 1227.31 ± 1.22 negative
1/2,000 (5 μl) 2.4 ± 1.2 2289.34 ± 479.07 6.80 ± 9.61 1252.49 ± 2.92 30 mg/dL
1/500 (20 μl) 10.0 ± 4.4 3633.39 ± 2006.87 16.62 ± 22.17 1258.43 ± 13.48 100 mg/dL
1/200 (50 μl) 17.3 ± 3.0 7898.05 ± 184.67 31.90 ± 43.19 1273.16 ± 5.53 300 mg/dL
  1. *hpf high power field.